COVID-19 living evidence synthesis #6 (version 6.41): What is the efficacy and effectiveness of available COVID-19 vaccines in general and specifically for variants of concern?

Iorio, A; Little, J; Linkins, L; Abdelkader, W; Bennett, D; Lavis, JN

COVID-19 living evidence synthesis #6 (version 6.41): What is the efficacy and effectiveness of available COVID-19 vaccines in general and specifically for variants of concern?

dc.contributor.author	Iorio, A
dc.contributor.author	Little, J
dc.contributor.author	Linkins, L
dc.contributor.author	Abdelkader, W
dc.contributor.author	Bennett, D
dc.contributor.author	Lavis, JN
dc.date.accessioned	2025-09-17T18:19:17Z
dc.date.available	2025-09-17T18:19:17Z
dc.date.issued	2022-09
dc.description.abstract	An in-depth synthesis of what is known, based on the best available research evidence from around the world (i.e., evidence syntheses) and local research evidence (i.e., single studies), about the efficacy and effectiveness of available COVID-19 vaccines in general and specifically for variants of concern.	en_US
dc.description.sponsorship	The development and continued updating of this living evidence synthesis has been funded by the Canadian Institutes of Health Research (CIHR) and the Public Health Agency of Canada.	en_US
dc.identifier.citation	Iorio A, Little J, Linkins L, Abdelkader W, Bennett D, Lavis JN. COVID-19 living evidence synthesis #6 (version 6.41): What is the efficacy and effectiveness of available COVID-19 vaccines in general and specifically for variants of concern? Health Information Research Unit (HIRU); McMaster and Ottawa Knowledge Synthesis and Application Unit, 14 September 2022.	en_US
dc.identifier.uri	http://hdl.handle.net/11375/32313
dc.language.iso	en	en_US
dc.relation.ispartofseries	LES 6.41;
dc.subject	efficacy	en_US
dc.subject	effectiveness	en_US
dc.subject	COVID-19	en_US
dc.subject	vaccines	en_US
dc.subject	variants	en_US
dc.title	COVID-19 living evidence synthesis #6 (version 6.41): What is the efficacy and effectiveness of available COVID-19 vaccines in general and specifically for variants of concern?	en_US

Files

Original bundle

Now showing 1 - 1 of 1

Name:: COVID-19 Living Evidence Synthesis 6.41 - What is the efficacy and effectiveness of available COVID-19 vaccines in general and specifically for variants of concern.pdf
Size:: 1.29 MB
Format:: Adobe Portable Document Format

Download

License bundle

Now showing 1 - 1 of 1

Name:: license.txt
Size:: 1.68 KB
Format:: Item-specific license agreed upon to submission
Description:

Download

Collections

Living evidence synthesis